Smarter Delivery Systems for Pharmaceutical Enzymes

• Oct 1, 2025
• AQ Bio Editorial
• Pharmaceutical Enzymes

Smarter Delivery Systems for Pharmaceutical Enzymes

Stability and bioavailability remain the twin challenges of enzyme therapeutics and specialty pharma formulations.

Enzymes are powerful catalysts, but they are also sensitive molecules. Heat, moisture, pH extremes, and processing shear can reduce activity before a product ever reaches the patient or end user.

Modern delivery thinking focuses on protecting enzyme activity through better excipient systems, coating technologies, controlled-release formats, and careful process design. In research settings, nano- and micro-encapsulation approaches are also explored to improve targeting and stability.

For commercial manufacturers, the practical wins often come from selecting high-stability grades, validating in-process controls, and matching enzyme type to dosage form — tablet, capsule, powder, or topical system.

AQ Bio Solutions supplies pharmaceutical enzymes such as bromelain, serratiopeptidase, trypsin–chymotrypsin mixes, pancreatin, pepsin, and fungal diastase with documentation suited to formulation teams.

Partner with us when your pipeline needs consistent enzyme activity and responsive technical support from sample to scale-up.